Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study. | Br J Cancer;92(5): 815-9, 2005 Mar 14. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study.

Maraveyas, A; Sgouros, J; Upadhyay, S; Abdel-Hamid, A-H; Holmes, M; Lind, M.

Affiliation

Maraveyas A; Department of Academic Oncology and University of Hull, Saltshouse Road, Hull HU8 9HE, UK. A.Maraveyas@hull.ac.uk

Br J Cancer ; 92(5): 815-9, 2005 Mar 14.

Article in En | MEDLINE | ID: mdl-15714201

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiation-Sensitizing Agents / Brain Neoplasms / Deoxycytidine Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2005 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiation-Sensitizing Agents / Brain Neoplasms / Deoxycytidine Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2005 Document type: Article Affiliation country: